Poland· PL-100452836
Beplasot
A tamsulosin und solifenacin product containing solifenacini succinas + tamsulosini hydrochloridum, registered in Poland by +pharma arzneimittel GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tamsulosin und solifenacin is registered in 9 of 19 countries.
Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Tamsulosin und solifenacin · ATC G04CA53
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Solifenacini succinas + Tamsulosini hydrochloridum
- Manufacturer
- +pharma arzneimittel GmbH
- Country
- Poland (PL)
- ATC code
- G04CA53
- ATC class
- Tamsulosin und Solifenacin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
1 priced- gtin0590172014109530 szt.PLN 30.3
- gtin05901720141101
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tamsulosin und solifenacin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- NetherlandsJomil 6 mg/0,4 mg, tabletten met gereguleerde afgifteHeaton k.s.
- SpainBITAMSOL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFGLaboratorios Q Pharma S.L.
- United KingdomSolifenacin 6mg / Tamsulosin 400microgram modified-release tabletsA A H Pharmaceuticals Ltd
- IrelandSolifenacin succinate/Tamsulosin hydrochloride Clonmel 6 mg/0.4 mg modified-release tabletsClonmel Healthcare Ltd
- GermanySolifenacin/Tamsulosin HeumannHeumann Pharma Gmbh & Co. Generica Kg
- NorwaySolifenacin/Tamsulosin NewburyNewbury Pharmaceuticals AB
- FinlandSolifenacin/Tamsulosin STADASTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Solicomp, Solifenacin/Tamsulosin Stada
- Belgium · Solifenacine / Tamsulosine Eurogenerics, Solifenacine/Tamsulosine
- Bulgaria · Везира, Везомни
- Cyprus · Nefilin
- Czechia · Beplasot, Jomil
- Germany · Solifenacin/Tamsulosin Heumann, Solifenacin/Tamsulosin Ratiopharm
- Denmark · Solifenacin/Tamsulosin Adalvo, Solifenacin/Tamsulosin Newbury
- Estonia · Solitombo
- Spain · Blobax, Daital
- Finland · Solifenacin/Tamsulosin Stada, Urizia
- France · Vecalmys
- United Kingdom (Northern Ireland) · Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science, Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science Limited
- Greece · Desoltam, Nefilin
- Croatia · Beplasot, Semquest
- Hungary · Mingerlan, Örgunderin
- Ireland · Solifenacin Succinate/Tamsulosin, Solifenacin Succinate/Tamsulosin Hydrochloride Clonmel
- Iceland · Soltamcin
- Italy · Luracin, Solifenacina E Tamsulosin Mylan
- Lithuania · Solitombo
- Luxembourg · Solifenacine/Tamsulosine, Solifenacine/Tamsulosine Eurogenerics
- Malta · Jomil
- Netherlands · Jomil, Mingerlan
- Norway · Solifenacin/Tamsulosin Newbury, Solifenacin/Tamsulosin Stada
- Portugal · Blatan, Solifenacina + Tansulosina Generis
- Romania · Mingerlan, Solifenacin/Tamsulosin Gemax Pharma
- Sweden · Urizia
- Slovenia · Semquest, Solifenacin/Tamsulozin Belupo
- Slovakia · Jomil, Solifenacín/Tamsulozín Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9cb0f8d-064f-4941-a02a-ecb05a7a2f3d GET /v1/drugs/f9cb0f8d-064f-4941-a02a-ecb05a7a2f3d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o zmodyfikowanym uwalnianiu",
"source": "urpl",
"strength": "6 mg + 0,4 mg",
"packaging": "05901720141095 ¦ Rp ¦ 151058\n30 tabl.\n05901720141101 ¦ Rp ¦ 151059\n90 tabl.",
"substance": "Solifenacini succinas 6 mg + Tamsulosini hydrochloridum 0.4 mg",
"common_name": "Solifenacini succinas + Tamsulosini hydrochloridum",
"pl_product_id": "100452836",
"pozwolenie_nr": "27973",
"auth_procedure": "DCP",
"authorisation_validity": "2028-08-30"
}See everything about tamsulosin und solifenacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.